177 related articles for article (PubMed ID: 36136255)
41. Predictors of Immediate Remission after Surgery in Cushing's Disease Patients: A Large Retrospective Study from a Single Center.
Dai C; Fan Y; Liu X; Bao X; Yao Y; Wang R; Feng M
Neuroendocrinology; 2021; 111(11):1141-1150. PubMed ID: 32512562
[TBL] [Abstract][Full Text] [Related]
42. Long-term remission and recurrence rates after first and second transsphenoidal surgery for Cushing's disease: care reality in the Munich Metropolitan Region.
Dimopoulou C; Schopohl J; Rachinger W; Buchfelder M; Honegger J; Reincke M; Stalla GK
Eur J Endocrinol; 2014 Feb; 170(2):283-92. PubMed ID: 24217937
[TBL] [Abstract][Full Text] [Related]
43. Management of Cushing's disease: a single-center experience.
Solak M; Kraljevic I; Dusek T; Melada A; Kavanagh MM; Peterkovic V; Ozretic D; Kastelan D
Endocrine; 2016 Mar; 51(3):517-23. PubMed ID: 26215278
[TBL] [Abstract][Full Text] [Related]
44. Repeat endoscopic endonasal transsphenoidal surgery for residual or recurrent cushing's disease: safety, feasibility, and success.
Hanalioglu S; Gurses ME; Gecici NN; Baylarov B; Isikay I; Gürlek A; Berker M
Pituitary; 2024 Jun; 27(3):259-268. PubMed ID: 38748309
[TBL] [Abstract][Full Text] [Related]
45. The role of reoperation after recurrence of Cushing's disease.
Cardinal T; Zada G; Carmichael JD
Best Pract Res Clin Endocrinol Metab; 2021 Mar; 35(2):101489. PubMed ID: 33814302
[TBL] [Abstract][Full Text] [Related]
46. Low immediate postoperative serum-cortisol nadir predicts the short-term, but not long-term, remission after pituitary surgery for Cushing's disease.
Ramm-Pettersen J; Halvorsen H; Evang JA; Rønning P; Hol PK; Bollerslev J; Berg-Johnsen J; Helseth E
BMC Endocr Disord; 2015 Oct; 15():62. PubMed ID: 26499317
[TBL] [Abstract][Full Text] [Related]
47. [Predictors of long-term remission after transsphenoidal surgery in Cushing's disease].
Abellán Galiana P; Fajardo Montañana C; Riesgo Suárez PA; Gómez Vela J; Escrivá CM; Lillo VR
Endocrinol Nutr; 2013 Oct; 60(8):475-82. PubMed ID: 23266144
[TBL] [Abstract][Full Text] [Related]
48. Central diabetes insipidus after transsphenoidal surgery in dogs with Cushing's disease.
Teshima T; Hara Y; Taoda T; Teramoto A; Tagawa M
J Vet Med Sci; 2011 Jan; 73(1):33-9. PubMed ID: 20736519
[TBL] [Abstract][Full Text] [Related]
49. [Factors influencing the recurrence of Cushing's disease treated by transsphenoidal surgery].
Xia XW; Su CB; Ren ZY; Wang RZ; Yang Y; Ma WB; Li YN; Kong YG
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):415-7. PubMed ID: 16900647
[TBL] [Abstract][Full Text] [Related]
50. Long-term follow-up results of transsphenoidal surgery for Cushing's disease in a single centre using strict criteria for remission.
Rees DA; Hanna FW; Davies JS; Mills RG; Vafidis J; Scanlon MF
Clin Endocrinol (Oxf); 2002 Apr; 56(4):541-51. PubMed ID: 11966748
[TBL] [Abstract][Full Text] [Related]
51. Surgical and radiosurgical treatment strategies for Cushing's disease.
Bunevicius A; Laws ER; Vance ML; Iuliano S; Sheehan J
J Neurooncol; 2019 Dec; 145(3):403-413. PubMed ID: 31677031
[TBL] [Abstract][Full Text] [Related]
52. Transsphenoidal pituitary surgery via the endoscopic technique: results in 35 consecutive patients with Cushing's disease.
Netea-Maier RT; van Lindert EJ; den Heijer M; van der Eerden A; Pieters GF; Sweep CG; Grotenhuis JA; Hermus AR
Eur J Endocrinol; 2006 May; 154(5):675-84. PubMed ID: 16645014
[TBL] [Abstract][Full Text] [Related]
53. Pituitary tumor apoplexy in patients with Cushing's disease: endocrinologic and visual outcomes after transsphenoidal surgery.
Choudhry OJ; Choudhry AJ; Nunez EA; Eloy JA; Couldwell WT; Ciric IS; Liu JK
Pituitary; 2012 Sep; 15(3):428-35. PubMed ID: 21927887
[TBL] [Abstract][Full Text] [Related]
54. Morbidity of repeat transsphenoidal surgery assessed in more than 1000 operations.
Jahangiri A; Wagner J; Han SW; Zygourakis CC; Han SJ; Tran MT; Miller LM; Tom MW; Kunwar S; Blevins LS; Aghi MK
J Neurosurg; 2014 Jul; 121(1):67-74. PubMed ID: 24834943
[TBL] [Abstract][Full Text] [Related]
55. The postoperative basal cortisol and CRH tests for prediction of long-term remission from Cushing's disease after transsphenoidal surgery.
Lindsay JR; Oldfield EH; Stratakis CA; Nieman LK
J Clin Endocrinol Metab; 2011 Jul; 96(7):2057-64. PubMed ID: 21508126
[TBL] [Abstract][Full Text] [Related]
56. National trends, complications, and outcomes following transsphenoidal surgery for Cushing's disease from 1993 to 2002.
Patil CG; Lad SP; Harsh GR; Laws ER; Boakye M
Neurosurg Focus; 2007; 23(3):E7. PubMed ID: 17961019
[TBL] [Abstract][Full Text] [Related]
57. Reoperative endoscopic endonasal surgery for residual or recurrent pituitary adenomas.
Negm HM; Al-Mahfoudh R; Pai M; Singh H; Cohen S; Dhandapani S; Anand VK; Schwartz TH
J Neurosurg; 2017 Aug; 127(2):397-408. PubMed ID: 27791524
[TBL] [Abstract][Full Text] [Related]
58. Olfactory functions after transsphenoidal pituitary surgery: endoscopic versus microscopic approach.
Kahilogullari G; Beton S; Al-Beyati ES; Kantarcioglu O; Bozkurt M; Kantarcioglu E; Comert A; Unlu MA; Meco C
Laryngoscope; 2013 Sep; 123(9):2112-9. PubMed ID: 23835915
[TBL] [Abstract][Full Text] [Related]
59. Surgical management of pediatric Cushing's disease: an analysis of 15 consecutive cases at a specialized neurosurgical center.
Oliveira RS; Castro Md; Antonini SR; Martinelli CE; Moreira AC; Machado HR
Arq Bras Endocrinol Metabol; 2010 Feb; 54(1):17-23. PubMed ID: 20414543
[TBL] [Abstract][Full Text] [Related]
60. Factors influencing cure by transsphenoidal selective adenomectomy in paediatric Cushing's disease.
Storr HL; Afshar F; Matson M; Sabin I; Davies KM; Evanson J; Plowman PN; Besser GM; Monson JP; Grossman AB; Savage MO
Eur J Endocrinol; 2005 Jun; 152(6):825-33. PubMed ID: 15941921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
